30,000
Participants
Start Date
November 30, 2014
Primary Completion Date
June 30, 2016
Study Completion Date
December 31, 2016
Arm 1: E-portal message with IVR call
Active electronic patient portal users will be randomized to receive an e-portal message and IVR calls. Both methods of outreach will provide patients with educational information about influenza vaccination, notify patients of local flu clinic schedules and elicit patient response to vaccination status and barriers.
Arm 2: E-portal message with no IVR call
Active electronic patient portal users will be randomized to receive only an e-portal message. The e-portal message will provide patients with educational information about influenza vaccination, notification of local flu clinic schedules and elicit patient response to vaccination status and barriers.
Arm 3: No e-portal message with IVR call
Active electronic patient portal users will be randomized to receive an IVR call. The IVR call will provide patients with educational information about influenza vaccination, notification of local flu clinic schedules and elicit patient response to vaccination status and barriers.
Arm 5: IVR call
Non electronic patient portal users will be randomized to receive an IVR call with educational information about influenza vaccines, notification of local flu clinic schedules and elicit patient response to vaccination status and barriers.
Reliant Medical Group, Worcester
Collaborators (1)
Reliant Medical Group
OTHER
Pfizer
INDUSTRY
University of Massachusetts, Worcester
OTHER